First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT

Medical physics. Medical radiology. Nuclear medicine R895-920
DOI: 10.1186/s13550-025-01204-y Publication Date: 2025-02-20T15:16:56Z